Prevalence and determinants of TB/HIV coinfection: the double tragedy of infectious disease burden – a 5-year retrospective study in a tertiary health facility in Enugu State, Nigeria Authors: Hope Obiageli Nwoga, Chukwuma Paulinus Igweagu, Gabriel Chukwuemeka Umeh Published: 2024 ABSTRACT AbstractObjectiveTo ascertain the prevalence and determinants of tuberculosis (TB)/HIV coinfection in Enugu State Nigeria.Study designA 5-year record-based retrospective study (2018–2022) conducted at a tertiary health facility to identify TB/HIV coinfections.SettingAbout 483 patients treated for TB at the centre were included in the study.Primary outcome measureThe χ2 test was used to test for association between the background characteristics of the patients (age, gender, place of residence, educational level, marital status, occupation, ethnicity and type of TB) and TB/HIV coinfection, while logistic regression was used to determine predictors of TB/HIV coinfection.ResultsOf the 483 patients with TB treated within the study period (2018–2022), all of them were screened for HIV and 29.0% of them had TB/HIV coinfection. The prevalence of TB/HIV coinfection was highest in 2021 (27.1%). On logistic regression, TB/HIV coinfection was more likely among traders (adjusted OR, AOR 4.932, 95% CI 1.364, 17.839) and students (AOR 2.772, 95% CI 1.014, 7.577). Those diagnosed in 2022 (AOR 0.514, 95% CI 0.272, 0.969) and those who reside in urban areas (AOR 0.594, 95% CI 0.372, 0.949) had lower odds of having TB/HIV coinfection.ConclusionAlmost one-third of all the patients with TB (29.0%) treated at the health facility were HIV coinfected. Occupation of the patients was found to predict TB/HIV coinfection as traders had the highest odds of TB/HIV coinfection when compared with the other occupational groups. Targeted interventions should be geared towards these groups of persons for better prevention and control of both TB and HIV infections in the State. STRENGTHS AND LIMITATIONS OF THIS STUDY This study was conducted in one of the busiest tertiary health facilities in Enugu State, Nigeria that caters to patients from within and outside the state and accepts referrals from primary, secondary and other tertiary health facilities. This study was conducted in one of the busiest tertiary health facilities in Enugu State, Nigeria that caters to patients from within and outside the state and accepts referrals from primary, secondary and other tertiary health facilities. The 5-year pool of data increased the statistical power of the study. The 5-year pool of data increased the statistical power of the study. The study used secondary data, as such some information on risk factors needed to characterise tuberculosis (TB)/HIV coinfection like substance abuse and sexual activities was missing. The study used secondary data, as such some information on risk factors needed to characterise tuberculosis (TB)/HIV coinfection like substance abuse and sexual activities was missing. The study was performed only on patients who presented in the health facility for treatment, thus, the overall prevalence of TB/HIV coinfection could have been underestimated. The study was performed only on patients who presented in the health facility for treatment, thus, the overall prevalence of TB/HIV coinfection could have been underestimated. The study was a single-centre study and the results may not be generalised for other centres. The study was a single-centre study and the results may not be generalised for other centres. Background Tuberculosis (TB) and HIV are a double burden of infections that pose a major public health challenge globally, especially in sub-Saharan Africa. TB is the leading immune-suppressing infection and the most common cause of mortality among HIV-infected patients globally.1 Furthermore, TB and HIV work together to suppress the patient’s immunity and, thereby, shorten their lifespan if prompt and adequate treatment is not given.2 WHO estimates that HIV-positive patients are 15–21 times at higher risk of acquiring TB than their HIV-negative counterparts.3 Both TB and HIV influence each other’s progression as HIV infection can cause TB progression from the latent phase to the active phase and increase the incidence of TB.4 In the same way, TB can also promote disease progression in HIV-positive patients and affect the treatment outcomes, quality of life and survival duration of patients with HIV/AIDS.5 6 Hence, TB/HIV coinfection is not just a combination of diseases; rather, they interact to accelerate each other’s progression. The duo of TB/HIV coinfection has become an important and urgent public health problem. WHO reported that TB accounts for approximately 30% of AIDS-related deaths worldwide.3 Of the estimated 400 000 annual deaths recorded for patients with TB/HIV coinfection worldwide, approximately 51% of the mortalities are known to occur in sub-Saharan Africa.7 The challenges associated with TB/HIV coinfections diagnosis and treatment constitute a huge burden on the healthcare systems of developing countries such as Nigeria. The global burden of HIV/AIDS has increased substantially since the epidemic of HIV/AIDS and this has altered the epidemiology of TB by increasing the risk of reactivating latent TB, increasing the chance of TB infection once exposed to tubercle bacilli (reinfection) and increasing the risk of rapid progression soon after infection8 as a result of compromised immunity in HIV/AIDS patients.9 Also the mortality and morbidity of coinfected patients are high compared with isolated infections with TB or HIV.10 Complications associated with treatment outcomes of TB/HIV coinfected patients results mostly from the concomitant use of antiretroviral treatment and the intensive phase of anti-TB medications. This leads to drug–drug interactions, increased pill burden, decreased adherence, side effects of multiple drugs and the development of higher rates of drug-resistant organisms because of the combination of these factors.11 The 2014 global TB control reports that the African region accounts for 74% of the 1.2 million TB/HIV cases globally12 with Nigeria being among the 30 high-burden countries for TB/HIV coinfection.13 Nigeria also ranked as the country with the highest TB burden in sub-Saharan Africa14 with a prevalence and incidence of 322 and 338 per 100 000 population, respectively.15 It has also been reported that TB lowers the CD4 count and worsens the immunodeficiency caused by HIV16 by increasing diversity and replication of HIV due to the facilitation of transcription of HIV genes.12 The incidence of TB/HIV coinfection has been reported to be influenced by many factors such as family size, anaemia, injectable drug use, clinical stage of HIV and use of antiretroviral therapy.12 TB/HIV coinfection is a relatively new and emerging public health challenge associated with TB control in Nigeria. Hence, studies on TB/HIV coinfection in Nigeria are limited. From my search, TB/HIV coinfection has not been studied in Enugu state. Given this, it is important to understand the prevalence and determinants of this double burden of TB/HIV coinfection to formulate realistic and evidence-based interventions for better control of both diseases both at the patient level and population level. Based on this significant gap in research, this study aimed to ascertain the prevalence of TB/HIV coinfection and its determinants in a tertiary health facility in Enugu State, Nigeria. The results of this study will provide background knowledge of TB/HIV coinfection in Enugu State and inform policymakers and others in TB/HIV control to develop interventions to address this public health challenge in the state. Materials and methods Study site The study was conducted at the chest and TB clinic of Enugu State University of Science and Technology Teaching Hospital (ESUT-TH) Park Lane Enugu, Nigeria where patients diagnosed with TB receive treatment. This clinic offers TB services for patients from within and outside Enugu State. It also accepts referrals from both government and private health facilities within and outside the state. ESUT-TH Parklane is a Public Hospital located at GRA Enugu North Local Government area of Enugu State, South East Nigeria. This facility offers primary, secondary and, tertiary healthcare services to persons of all social classes and is one of the referral centres for the population of Enugu State and its environs. Enugu state population is mainly Agrarian, trading activities at all levels and civil/public servants make it an ideal place for TB and HIV studies. Study design The study was a 5-year record-based retrospective study (2018–2022) of all TB cases treated at the TB clinic of ESUT-TH Parklane Enugu Nigeria. Source of data All the data were retrieved from the patient’s folders stored in the records section of the TB and chest clinic of the hospital. Any unclear information was cross-checked with the patients registered at the same clinic. The information was entered into a proforma. Patients with incomplete information on HIV status and evidence of TB diagnosis were excluded from the study. Kindly note that the data used in this article are part of a larger dataset collected from the study site. The sociodemographic characteristics of the patients receiving TB care at the centre have been published separately in order to discuss it in details, as social determinants of health play an important role in resource-poor countries like ours. No other data related to the one used in the present manuscript have been published. Data coding, processing and analysis Data retrieved from the patient’s folders were entered into SPSS V.25. Descriptive statistics were done to clean the data and check for any missing data. Univariate analysis was done and presented as mean, SD, frequencies and percentages. Bivariate analysis was done with χ2 to test for association between the outcome variable (TB/HIV coinfection) and the background characteristics (age, gender, place of residence, educational level, occupation, marital status, ethnicity and type of TB) with significant level placed at ≤0.05. Variables that were statistically significant on bivariate analysis were imputed into logistic regression to determine the predictors of TB/HIV coinfection at a 95% CI. Patient and public involvement The study used only secondary data from patient’s folders. No patient was directly involved in the data extraction and/or analysis. Results A total of 483 patients with TB were reviewed. Table 1 shows the background characteristics of the patients with TB used for the study. More of the cases were seen in 2022 (26.1%). The mean age was 38.91±17.39. Most of the cases were in the 30–39 years age group (24.8%). About two-thirds of them were males (61.9%) and urban dwellers (65.0%). Most had secondary education (46.2%) and traders (27.5%). About half of them were married (51.6%) while almost all were Igbos (95.4%). The overall prevalence of TB/HIV coinfection was 29.0%. Table 1Background characteristics of the patientsVariableFrequency (N=483)PercentageYear 20189018.6 20198417.4 20208617.8 20219720.1 202212626.1Age (years)Mean±SD38.91±17.39Age in groups (years) 0–9142.9 10–19418.5 20–299920.5 30–3912024.8 40–498317.2 50–595511.4 60–69387.9 ≥70336.8Gender Male29961.9 Female18438.1Place of residence Rural16935.0 Urban31465.0Educational level None153.1 Primary completed10922.5 Secondary completed22346.2 Tertiary completed13628.2Occupation Civil/public servants428.7 Traders13327.5 Crafts/artisans8617.8 Farmers347.0 Unemployed11123.1 Students7715.9Marital status Single20742.9 Married24951.6 Divorced/separated40.8 Widow/widower234.7Ethnicity Igbo46195.4 Hausa132.7 Yoruba10.2 Others81.7HIV status Positive14029.0 Negative34371.0 Background characteristics of the patients Table 2 shows the prevalence of TB/HIV coinfection by patient’s background characteristics. The highest coinfection was among the 30–39 age group (35.0%), followed by the 40–49 age group (29.2%). More than half were males (57.9%) and reside in the urban area (57.1%). About half of them had secondary education (47.9%) and were married (47.9%). Most of them were traders while the majority were of the Igbo ethnic group (97.2%), had new cases (86.5%) and had pulmonary TB (95.0%). Table 2Prevalence of TB/HIV coinfection by patients background characteristicsVariableFrequency N=140PercentageAge in groups (years) 0–975.0 10–19117.9 20–291712.1 30–394935.0 40–494129.2 50–59117.9 60–6942.9Gender Male8157.9 Female5942.1Residence Rural6042.9 Urban8057.1Educational level None53.5 Primary completed3525.0 Secondary6747.9 Tertiary3323.6Occupation Civil/public servants64.3 Trading5841.4 Crafts/artisans3021.4 Farmers53.6 Unemployed1812.9 Student2316.4Marital status Single6244.3 Married6747.9 Divorced/separated32.1 Widowed85.7Ethnicity Igbo13697.2 Hausa32.1 Others10.7Status of the present case New case12186.5 Relapsed case96.4 Drug-resistant case10.7 TALF96.4Type of TB Pulmonary13395.0 Extrapulmonary64.3 Pulmonary+extrapulmonary10.7TALF, Treatment after loss to follow-upTBtuberculosis Prevalence of TB/HIV coinfection by patients background characteristics TALF, Treatment after loss to follow-upTBtuberculosis Figure 1 shows the trend of TB-HIV coinfection within the study year. It shows an undulating pattern within the 5-year period (2018–2022). It increased from 2018 to 2019 and declined in 2020 before another increase in 2021 that declined slightly in 2022. Prevalence of TB/HIV coinfection. TB, tuberculosis. Table 3 shows the result of the bivariate analysis. Year of diagnosis and treatment (p=0.035), age (p<0.001), place of residence (p=0.021), occupation (p<0.001) and type of TB (p=0.009) were statistically significantly associated with TB/HIV coinfection. Table 3Bivariate analysis of TB/HIV coinfection and patients background characteristicsVariableHIV statusX2P valuePositiveNegativeYear 201823 (25.6)67 (74.4)10.3270.035* 201927 (32.1)57 (67.9) 202016 (18.6)70 (81.4) 202138 (39.2)59 (60.8) 202236 (28.6)90 (71.4)Gender Male81 (27.1)218 (72.9)1.3700.242 Female59 (32.1)125 (67.9)Age in groups (years) 0–97 (50.0)7 (50.0)56.710<0.001* 10–1911 (26.8)30 (73.2) 20–2917 (17.2)82 (82.8) 30–3949 (40.8)71 (59.2) 40–4941 (49.4)42 (50.6) 50–5911 (20.0)44 (80.0) 60–694 (10.5)34 (89.5) ≥700 (0.0)33 (100.0)Place of residence Rural60 (35.5)109 (64.5)5.3650.021* Urban80 (25.5)234 (74.5)Educational level None5 (33.3)10 (66.7)2.2490.522 Primary completed35 (32.1)74 (67.9) Secondary67 (30.0)156 (70.0) Tertiary33 (24.3)103 (75.7)Occupation Civil/public servants6 (14.3)36 (85.7)31.870<0.001* Trading58 (43.6)75 (56.4) Crafts/artisans30 (34.9)56 (65.1) Farmers5 (14.7)29 (85.3) Unemployed18 (16.2)93 (83.8) Student23 (29.9)54 (70.1)Marital status Single62 (30.0)145 (70.0)5.1060.164 Married67 (26.9)182 (73.1) Divorced/separated3 (75.0)1 (25.0) Widowed8 (34.8)15 (65.2)Ethnicity Igbo136 (29.5)325 (70.5)1.7440.627 Hausa3 (23.1)10 (76.9) Yoruba0 (0.0)1 (100.0) Others1 (12.5)7 (87.5)Type of TB Pulmonary133 (31.3)292 (68.7)9.5130.009* Extrapulmonary6 (11.1)48 (88.9) Pulmonary and extrapulmonary1 (25.0)3 (75.0)*Significant values.TBtuberculosis Bivariate analysis of TB/HIV coinfection and patients background characteristics Significant values. TBtuberculosis Table 4 shows predictors of TB/HIV coinfection. Those diagnosed in 2022 (adjusted OR, AOR 0.514, 95% CI 0.272, 0.969), urban dwellers (AOR 0.594, 95% CI 0.372, 0.949) and occupation (traders, AOR 4.932, 95% CI 1.364, 17.839; students, AOR 2.772, 95% CI 1.014, 7.577) predicted TB/HIV coinfection in the study. Those who were diagnosed in 2022 had about 0.486 lesser odds of having TB/HIV coinfection when compared with those diagnosed in 2018. Those who reside in urban areas also had a 0.406 lesser odds of having TB/HIV coinfection when compared with those who reside in rural areas. Traders had five times the odds of having TB/HIV coinfection when compared with civil servants, also students had about three times the odds of having TB/HIV coinfection when compared with civil servants. Table 4Predictors of TB/HIV coinfectionVariableAdjusted ORP value95% CIlower upperYear 20181 20190.9690.9260.4941.899 20200.7380.3780.3751.451 20211.3940.3790.6662.920 20220.5140.040*0.2720.969Age <301 >300.0010.998Place of residence Rural1 Urban0.5940.029*0.3720.949Occupation Civil/public servants1 Trading4.9320.015*1.36417.839 Crafts/artisans1.0620.9070.3912.882 Farmers1.2090.7210.4263.433 Unemployed2.9770.1410.69612.741 Student2.7720.047*1.0147.577Type of TB Pulmonary1 Extrapulmonary0.2440.2590.0212.823 Pulmonary and extrapulmonary1.2780.8530.09517.218*Significant values.TBtuberculosis Predictors of TB/HIV coinfection Significant values. TBtuberculosis Discussions The aim of this study was to ascertain the prevalence of TB/HIV coinfection and its determinants in a tertiary health facility in Enugu State, Nigeria. All the patients (100.0%) who tested positive for TB through any investigative procedure were screened for HIV. This was mandatory in the health facility as recommended by WHO. This is impressive and a sign of good TB care. Other studies from Ghana 62%,17 Kenya 96%18 and Zambia 96%19 reported varying levels of HIV screening among TB patients. These findings show that there is an increased interest in the need to screen TB patients for HIV in Africa generally. The prevalence of TB/HIV coinfection in this study was 29.0%. This shows a considerably high prevalence of TB/HIV coinfection in Nigeria. This prevalence is similar to what was reported in a systematic review conducted with Nigerian studies where the overall TB/HIV coinfection was 25.8% with a range of 21.6%–30.2%,20 and in Ethiopia21 but higher than the report of other studies13 22 and WHO reported estimate of 12% in 2015.23 Other similar studies reported higher findings in Nigeria 44.2%,24 Zimbabwe 44%,25 Ethiopia 44%,26 Cameroon 51.6%,27 and Ghana 46.2%28 and the 31.1% prevalence estimate for Africa.22 The differences reported in these studies can be explained by differences in sociodemographic characteristics, time of the study or sample size variation, differences in individual disease burden and the socioeconomic factors in the community. Studies have reported higher prevalence of TB/HIV coinfection among younger age groups, urban dwellers and those who are self-employed.29 30 Similar studies have also reported that there are differences in prevalence of TB/HIV in different local government areas within the same state.29 30 All these indicate that sociodemographics of a study population including the socioeconomic factors can affect the results. A health facility-based study from Ethiopia reported that HIV/TB coinfection was identified as a predictor of DM comorbidity in active TB patients and this explains how individual disease burden can affect the prevalence of TB/HIV coinfection.31 The high prevalence of TB/HIV coinfection in Nigeria as reported in the present study may be attributed to the lower standard of living in Nigeria compared with the other regions of the world. Nigeria is one of the 51 countries that are classified by the World Bank as either low-income or middle-lower-income countries and the majority of these countries are in sub-saharan Africa.32 Poverty and low standard of living which are known risk factors for TB infection also abound in Nigeria and most people dwell in overcrowded households further encouraging the spread of TB.16 The high prevalence of TB/HIV coinfection in Nigeria can also be ascribed to the high HIV seroprevalence in the country; accounting for the second-largest HIV epidemic in the world. Since Nigeria is among the high-burden countries for both TB and HIV, the high prevalence of TB/HIV coinfection reported in this study is not surprising and it is significantly higher than the 2017 coinfection estimate reported by the WHO (8%).33 This high prevalence of coinfection is a cause for concern considering the emerging risk due to multiple drug-resistant TB cases recorded in Nigeria13 and the efforts made by the Federal Government of Nigeria through the Ministry of Health towards reducing HIV and TB-associated morbidity and mortality. Hence, there is a need to review policy strategies to intensify prevention, early detection and comprehensive management of cases.12 Year of diagnosis, place of residence and occupation predicted TB/HIV coinfection in this study. Those who were diagnosed in 2022 had about 0.486 lesser odds of having TB/HIV coinfection when compared with those diagnosed in 2018. Although the prevalence of TB/HIV coinfection was undulating during the 5 years of the study, the lesser odds of coinfection recorded in 2022 may be due to better awareness of TB as the most common opportunistic infection among HIV-positive patients and better compliance to antiretroviral medications which will help to maintain a higher immunity hence reducing the incidence of opportunistic infections as TB. Contrastingly, a systematic review and meta-analysis reported that the year of diagnosis was not significantly associated with TB/HIV coinfection.20 Patients who reside in urban areas also had a 0.406 lesser odds of having TB/HIV coinfection when compared with those who reside in rural areas. This shows that those who reside in rural areas had higher odds of TB/HIV coinfection when compared with those who reside in urban areas. Another study reported a similar finding.34 In developing countries such as Nigeria, some of the rural areas are not accessible and they lack access to both TB and HIV treatment when compared with those in the urban areas. So those who are HIV positive can easily have either reactivation of a dormant TB focus or a new infection due to reduced immunity. Contrastingly, similar studies reported that place of residence was not significantly associated with TB/HIV coinfection.26 34 The difference may be explained by the state of the rural health facilities and the social class of the dwellers. Traders had five times the odds of having TB/HIV coinfection when compared with civil servants, also students had about three times the odds of having TB/HIV coinfection when compared with civil servants. The majority of these traders are always out of their homes and interact with a large number of people in the environment exposing them to TB infection. These same groups of people may engage in risky lifestyles like smoking, casual sex and alcohol abuse exposing them to HIV infection hence the higher rates of coinfection. The majority of these traders are young adult males who have been reported to have a higher prevalence of TB35 and TB/HIV coinfection.29 30 The students are also young people who may engage in risky behaviours like smoking, casual unprotected sex and alcohol abuse exposing them to both TB and HIV infections. TB is common among the young population,32 and even in this study, almost half of the patients were aged between 20 and 39 years. Hence, the findings were not surprising. Limitations of the study The study used secondary data that were already recorded. Thus, some of the important social factors (like the history of smoking in any form or alcohol consumption and sexual activities) that were needed to characterise the patient’s risk factors for TB/HIV coinfection were lacking and the results were based only on the data obtained from the patient’s folder. This was also a single facility-based study thus, the finding may not be generalised to the whole country. The study was performed only on patients who presented in the health facility for diagnosis and treatment, thus, the overall prevalence of TB/HIV coinfection could have been underestimated. Implications for policy and research The results of this study have important policy and research implications as it recorded a high prevalence of TB/HIV coinfection. This high prevalence shows that there is a need to review policy strategies to intensify prevention, early detection and comprehensive management of TB and HIV cases in Enugu State. Health education on TB/HIV coinfection can be used by the state ministry of health to enlighten the populace and encourage them to present to the hospital for early diagnosis and treatment. The study’s implication for research is that it has provided background information on the prevalence of TB/HIV coinfection in the state using one of the busiest tertiary health facilities as a research focus. The study can be taken further by conducting a prospective study to establish a causal relationship between the risk factors and TB/HIV coinfection. Furthermore, qualitative study methods like focus group discussions, in-depth interviews or key informant interviews can be used to get a deeper understanding of the on-site activities and cover some of the gaps in the present retrospective study. Conclusions The magnitude of TB/HIV coinfection is high in the study population. Residing in a rural area, being a trader and a student positively predicted TB/HIV coinfection. More collaborative efforts should be geared towards early diagnosis and treatment of both TB and HIVpositive patients to reduce this high rate of coinfection. The data recording system for patients should be improved to include other important factors that are necessary to properly characterise patient risk factors; such as occupation, history of substance use or abuse, income, family size and the presence of comorbidities.